Stegall, M. D., Troy Somerville, K., Everly, M. J., Mannon, R. B., Gaber, A. O., First, M. R., . . . O’Doherty, I. (2019). The importance of drug safety and tolerability in the development of new immunosuppressive therapy for transplant recipients: The Transplant Therapeutics Consortium’s position statement. American Journal of Transplantation, 19(3), 625-632. https://doi.org/10.1111/ajt.15214

Stegall, Mark D., et al. "The Importance of Drug Safety and Tolerability in the Development of New Immunosuppressive Therapy for Transplant Recipients: The Transplant Therapeutics Consortium’s Position Statement." American Journal of Transplantation 19, no. 3 (2019): 625-632. https://doi.org/10.1111/ajt.15214.

Stegall, Mark D., et al. "The Importance of Drug Safety and Tolerability in the Development of New Immunosuppressive Therapy for Transplant Recipients: The Transplant Therapeutics Consortium’s Position Statement." American Journal of Transplantation, vol. 19, no. 3, 2019, pp. 625-632, https://doi.org/10.1111/ajt.15214.